Welgene Biotech Co (6661.TWO) Akcja Kurs

Welgene Biotech Co., Ltd. engages in the provision of biotechnology services including genetic testing, molecular diagnosis, and bioinformatics support for universities, hospitals, pharmaceutical companies, and others. The company is headquartered in Taipei City, Taipei. The company went IPO on 2017-10-23. The firm focuses on deoxyribonucleic acid (DNA) microarray, Next Generation Sequencing and real-time quantitative polymerase chain reaction (PCR) and other testing technologies, which used in school research units, hospitals and biotech companies. The firm is also engaged in the trading of medical equipment. The firm mainly operates in two business segments, including Biotechnology Testing segment and Equipment Trading segment. The firm mainly operates in Taiwan market.